Canhera (Trastuzumab Vials) 150mg

CANHERA (Trastuzumab) 150mg vials are prescribed for certain types of cancer treatment. This monoclonal antibody targets HER2-positive cells to support therapy. CANHERA trastuzumab 150mg vial is used under medical supervision for targeted cancer care. Buy CANHERA online for HER2-positive cancer therapy.

Strength

150mg

Manufacturer / TM Owner

Abdi Ibrahim

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trastuzumab, the active ingredient in CANHERA 150mg vials, is used to treat HER2-positive breast cancer and HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma. It works by binding to the HER2 protein on cancer cells, helping to slow or stop their growth. CANHERA trastuzumab 150mg is typically administered as part of a combination therapy regimen. This medication is not suitable for all cancer types and should only be used as directed by a healthcare professional.

Side Effects

CANHERA (Trastuzumab) 150mg vials may help reduce the progression of HER2-positive cancer cells when used as prescribed. Patients often experience improved outcomes as part of a broader treatment plan. Common effects include fatigue, nausea, or infusion-related reactions during administration. Individual responses to CANHERA trastuzumab 150mg may vary based on treatment duration and health status.

Precautions & Warnings

CANHERA 150mg vials should be handled and administered by trained healthcare professionals in a clinical setting. Patients with known hypersensitivity to trastuzumab or any component of CANHERA should avoid its use. Regular monitoring of heart function is recommended during treatment due to potential cardiac effects. Keep CANHERA trastuzumab 150mg vials refrigerated and protected from light until use.

Avoid Interactions

Concurrent use of CANHERA (Trastuzumab) with other HER2-targeted therapies or cardiotoxic medications may increase the risk of side effects. Patients should inform their doctor about all medications, including over-the-counter drugs and supplements. CANHERA trastuzumab 150mg may interact with certain chemotherapy agents or antihypertensives. Avoid live vaccines during treatment with CANHERA due to potential immune system effects.

References

Frequently Asked Questions

CANHERA (trastuzumab) 150mg is used to treat HER2-positive breast cancer and HER2-positive metastatic gastric cancer as part of a prescribed therapy plan.

CANHERA trastuzumab 150mg is administered intravenously by a healthcare professional in a clinical setting, typically as part of a treatment cycle.

Common effects may include fatigue, nausea, or infusion-related reactions. Individual responses can vary based on treatment and health status.

CANHERA trastuzumab 150mg vials are available through licensed pharmacies and healthcare providers for prescribed use only.

CANHERA should only be used under medical supervision. Patients with known allergies or specific health conditions should consult their doctor before use.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.